IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Socinski, Mark A.; Nishio, Makoto; Jotte, Robert M.; Cappuzzo, Federico; Orlandi, Francisco; Stroyakovskiy, Daniil; Nogami, Naoyuki; Rodriguez-Abreu, Delvys; Moro-Sibilot, Denis; Thomas, Christian A.; Barlesi, Fabrice; Finley, Gene; Kong, Shengchun; Lee, Anthony; Coleman, Shelley; Zou, Wei; McCleland, Mark; Shankar, Geetha; Reck, Martin

authors

Publication Date

  • November 1, 2021

webpage

published in

category

keywords

  • Atezolizumab
  • Bev-acizumab
  • Chemotherapy
  • IMpower150
  • Non-small cell lung cancer

start page

  • 1909

end page

  • 1924

volume

  • 16

issue

  • 11